Bressi Jerome Charles sold FATE
January 10, 2025 · Form 4 insider transaction
Bressi Jerome Charles sold 5,980 shares of Fate Therapeutics, Inc. at $1.55 per share, a transaction worth $9.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,188 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021 and 6,660 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the Reporting Person.; Represents the weighted average sale price of the shares sold ranging from $1.51 to $1.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.